Pfizer and biontech celebrate historic first authorization in the u.s. of vaccine to prevent covid-19

New york and mainz, germany, december 11, 2020 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) announced today that the u.s. food and drug administration (fda) has authorized the emergency use of the mrna vaccine, bnt162b2, against covid-19 in individuals 16 years of age or older. the vaccine is now authorized under an emergency use authorization (eua) while pfizer and biontech gather additional data and prepare to file a planned biologics license application (bla) with the fda for a possible full regulatory approval in 2021.
BNTX Ratings Summary
BNTX Quant Ranking